Aldeyra Therapeutics (ALDX) PT Lowered to $21 at Citi
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Price: $1.48 --0%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Aldeyra Therapeutics (NASDAQ: ALDX) to $21.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Zscaler (ZS) PT Raised to $190 at FBN Securities
- CIENA (CIEN) PT Lowered to $394 at UBS on Group Multiple Compression
- Keyera Corp. (KEY:CN) (KEYUF) PT Lowered to Cdn$64 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
